Drugs / XG005-03
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04283474 | Feb 2020 → Jan 2021 | — | Xgene Pharmaceutical Group | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | XG005-03 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04283474 ↗ |
| Route | Topical | “after single and multiple topical applications” NCT04283474 ↗ |